Compare APLS & HUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APLS | HUN |
|---|---|---|
| Founded | 2009 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.3B |
| IPO Year | 2015 | 2004 |
| Metric | APLS | HUN |
|---|---|---|
| Price | $20.64 | $12.36 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 20 | 11 |
| Target Price | ★ $31.79 | $12.09 |
| AVG Volume (30 Days) | 1.9M | ★ 6.8M |
| Earning Date | 04-02-2026 | 05-20-2026 |
| Dividend Yield | N/A | ★ 2.77% |
| EPS Growth | ★ 112.50 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | $1,003,782,000.00 | ★ $5,683,000,000.00 |
| Revenue This Year | N/A | $4.01 |
| Revenue Next Year | $17.57 | $5.14 |
| P/E Ratio | $103.98 | ★ N/A |
| Revenue Growth | ★ 28.46 | N/A |
| 52 Week Low | $16.10 | $7.30 |
| 52 Week High | $30.48 | $18.08 |
| Indicator | APLS | HUN |
|---|---|---|
| Relative Strength Index (RSI) | 38.18 | 49.22 |
| Support Level | $18.95 | $10.76 |
| Resistance Level | $24.37 | $14.38 |
| Average True Range (ATR) | 0.97 | 0.85 |
| MACD | -0.14 | -0.17 |
| Stochastic Oscillator | 20.13 | 26.42 |
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Materials. It derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.